Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis

Detalles Bibliográficos
Autores principales: Esposito, Maria, De Berardinis, Andrea, Totaro, Rocco, Fargnoli, Maria Concetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706390/
https://www.ncbi.nlm.nih.gov/pubmed/36458235
http://dx.doi.org/10.1016/j.jdcr.2022.10.031
_version_ 1784840505732890624
author Esposito, Maria
De Berardinis, Andrea
Totaro, Rocco
Fargnoli, Maria Concetta
author_facet Esposito, Maria
De Berardinis, Andrea
Totaro, Rocco
Fargnoli, Maria Concetta
author_sort Esposito, Maria
collection PubMed
description
format Online
Article
Text
id pubmed-9706390
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97063902022-11-30 Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis Esposito, Maria De Berardinis, Andrea Totaro, Rocco Fargnoli, Maria Concetta JAAD Case Rep Case Series Elsevier 2022-11-05 /pmc/articles/PMC9706390/ /pubmed/36458235 http://dx.doi.org/10.1016/j.jdcr.2022.10.031 Text en © 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Series
Esposito, Maria
De Berardinis, Andrea
Totaro, Rocco
Fargnoli, Maria Concetta
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
title Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
title_full Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
title_fullStr Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
title_full_unstemmed Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
title_short Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
title_sort dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706390/
https://www.ncbi.nlm.nih.gov/pubmed/36458235
http://dx.doi.org/10.1016/j.jdcr.2022.10.031
work_keys_str_mv AT espositomaria dupilumabinpatientswithmoderatetosevereatopicdermatitisandmultiplesclerosis
AT deberardinisandrea dupilumabinpatientswithmoderatetosevereatopicdermatitisandmultiplesclerosis
AT totarorocco dupilumabinpatientswithmoderatetosevereatopicdermatitisandmultiplesclerosis
AT fargnolimariaconcetta dupilumabinpatientswithmoderatetosevereatopicdermatitisandmultiplesclerosis

Ejemplares similares